Journal
CELL CHEMICAL BIOLOGY
Volume 28, Issue 4, Pages 559-+Publisher
CELL PRESS
DOI: 10.1016/j.chembiol.2021.01.005
Keywords
-
Categories
Funding
- Novartis Institutes for BioMedical Research
- Novartis-Berkeley Center for Proteomics and Chemistry Technologies (NB-CPACT)
- Mark Foundation for Cancer Research ASPIRE Award
- NIH [R01CA240981, F31CA239327, F99CA253717]
- Nomura Research Group
Ask authors/readers for more resources
This study found that the natural product nimbolide can be used as a recruiter of the E3 ubiquitin ligase RNF114 for targeted protein degradation, which is important in modern drug discovery. Through activity-based protein profiling-enabled ligand screening, fully synthetic molecules mimicking nimbolide were discovered, showing potential for degrading therapeutic targets.
The translation of functionally active natural products into fully synthetic small-molecule mimetics has remained an important process in medicinal chemistry. We recently discovered that the terpene natural product nimbolide can be utilized as a covalent recruiter of the E3 ubiquitin ligase RNF114 for use in targeted protein degradation-a powerful therapeutic modality within modern-day drug discovery. Using activitybased protein profiling-enabled covalent ligand-screening approaches, here we report the discovery of fully synthetic RNF114-based recruiter molecules that can also be exploited for PROTAC applications, and demonstrate their utility in degrading therapeutically relevant targets, such as BRD4 and BCR-ABL, in cells. The identification of simple and easily manipulated drug-like scaffolds that can mimic the function of a complex natural product is beneficial in further expanding the toolbox of E3 ligase recruiters, an area of great importance in drug discovery and chemical biology.Y
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available